# A Clinical Trial of KT07 Capsule in the U.S.A

> **NCT02867358** · PHASE2 · COMPLETED · sponsor: **Yiling Pharmaceutical Inc.** · enrollment: 391 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **DRUG:** KT07 Capsule
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02867358
- **Lead sponsor:** Yiling Pharmaceutical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 391 (ACTUAL)
- **Last updated:** 2020-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02867358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02867358, "A Clinical Trial of KT07 Capsule in the U.S.A". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02867358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*